Goldhaber SZ - Search Results

1

Recognition of biomarker identified high-risk patients in the acute medically ill venous thromboembolism prevention with extended duration betrixaban study resulting in a protocol amendment.

Cohen AT, Harrington R, Goldhaber SZ, Hull R, Gibson CM, Hernandez AF, Gold A. Cohen AT, et al. Among authors: goldhaber sz. Am Heart J. 2015 Jan;169(1):186-7. doi: 10.1016/j.ahj.2014.09.004. Epub 2014 Sep 19. Am Heart J. 2015. PMID: 25497265 No abstract available.

2

Program for the prevention of venous thromboembolism in high-risk orthopaedic patients.

Reis SE, Hirsch DR, Wilson MG, Donovan BC, Goldhaber SZ. Reis SE, et al. Among authors: goldhaber sz. J Arthroplasty. 1991;6 Suppl:S11-6. doi: 10.1016/s0883-5403(08)80050-2. J Arthroplasty. 1991. PMID: 1774565

3

Frequency of deep venous thrombosis in asymptomatic patients with coronary artery bypass grafts.

Reis SE, Polak JF, Hirsch DR, Cohn LH, Creager MA, Donovan BC, Goldhaber SZ. Reis SE, et al. Among authors: goldhaber sz. Am Heart J. 1991 Aug;122(2):478-82. doi: 10.1016/0002-8703(91)91004-7. Am Heart J. 1991. PMID: 1858629

4

The effect of chronic platelet inhibition with low-dose aspirin on atherosclerotic progression and acute thrombosis: clinical evidence from the Physicians' Health Study.

Ridker PM, Manson JE, Buring JE, Goldhaber SZ, Hennekens CH. Ridker PM, et al. Among authors: goldhaber sz. Am Heart J. 1991 Dec;122(6):1588-92. doi: 10.1016/0002-8703(91)90275-m. Am Heart J. 1991. PMID: 1957753 Clinical Trial.

5

Shortened hospitalization by means of adjusted-dose subcutaneous heparin for deep venous thrombosis.

Hirsch DR, Lee TH, Morrison RB, Carlson W, Goldhaber SZ. Hirsch DR, et al. Among authors: goldhaber sz. Am Heart J. 1996 Feb;131(2):276-80. doi: 10.1016/s0002-8703(96)90354-3. Am Heart J. 1996. PMID: 8579021

6

Bolus recombinant urokinase versus heparin in deep venous thrombosis: a randomized controlled trial.

Goldhaber SZ, Hirsch DR, MacDougall RC, Polak JF, Creager MA. Goldhaber SZ, et al. Am Heart J. 1996 Aug;132(2 Pt 1):314-8. doi: 10.1016/s0002-8703(96)90427-5. Am Heart J. 1996. PMID: 8701892 Clinical Trial.

7

Chronic venous insufficiency: mechanisms and management.

Ibrahim S, MacPherson DR, Goldhaber SZ. Ibrahim S, et al. Among authors: goldhaber sz. Am Heart J. 1996 Oct;132(4):856-60. doi: 10.1016/s0002-8703(96)90322-1. Am Heart J. 1996. PMID: 8831377 Review.

8

Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence.

Nicolaides AN, Breddin HK, Fareed J, Goldhaber S, Haas S, Hull R, Kalodiki E, Myers K, Samama M, Sasahara A; Cardiovascular Disease Educational and Research Trust and the International Union of Angiology. Nicolaides AN, et al. Int Angiol. 2001 Mar;20(1):1-37. Int Angiol. 2001. PMID: 11342993 No abstract available.

9

Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.

Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ; PREVENT Medical Thromboprophylaxis Study Group. Leizorovicz A, et al. Among authors: goldhaber sz. Circulation. 2004 Aug 17;110(7):874-9. doi: 10.1161/01.CIR.0000138928.83266.24. Epub 2004 Aug 2. Circulation. 2004. PMID: 15289368 Clinical Trial.

10

Prevention of venous thromboembolism among hospitalized medical patients.

Goldhaber SZ, Turpie AG. Goldhaber SZ, et al. Circulation. 2005 Jan 4;111(1):e1-3. doi: 10.1161/01.CIR.0000150393.51958.54. Circulation. 2005. PMID: 15630031 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

737 results

Search Page

Filters